Santhera and Ipsen Enter into Licensing Agreement for Fipame-zole for the Treatment of Dyskinesia in Parkinson's Disease 03 September 2010 Ipsen acquires the rights to fipamezole outside the United States, Canada and Japan for an upfront payment of EUR 13 million.
Evotec Completes Acquisition of DeveloGen 03 September 2010 The transaction adds two complementary alliances - one with Boehringer Ingelheim and one with Andromeda to Evotec's portfolio of core assets.
Lonza Acquires Viral Vaccine and Vector Manufacturer Vivante GMP Solutions 31 August 2010 Lonza expands its custom service platform to viral vaccines and gene therapy vectors.
Thermo Scientific Announces New UHPLC/MS Method for Trace-Level Analysis of Perfluorinated Compounds in Human Breast Milk 27 August 2010 The method utilizes SRM and H-SRM on an integrated UHPLC/MS platform enables robust detection of PFCs at ppt concentrations.
ChemAxon Extends chemicalize.org Free Service with Predicted Data and User Customization 23 August 2010 The new features help users understand better the chemical structure with more predicted properties and a customizable layout.
Broad Institute Acquires License to all ChemAxon Products and Deploys Across Chemical Biology Platform 20 August 2010 License covers ChemAxon’s platform, discovery toolkits and desktop applications for institute-wide use.
Agilent and Johns Hopkins to Research Toxicity Pathways for Embryonic Brain Development Using Metabolomics 20 August 2010 The work could help identify possible contributions of chemicals to disorders such as autism and attention hyperactivity disorders.
Quark and Novartis Enter into Licensing Option Agreement for the p53 Suppressor Drug QPI-1002 20 August 2010 Novartis gains an exclusive worldwide license to develop and commercialize the p53 temporary inhibitor siRNA drug for $10 million.